2 weeks Bristol-Myers Squibb: Solid Q4 Earnings, But Weak Guidance And Patent Concerns Drive The Stock Down Seeking Alpha X
3 weeks Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain Seeking Alpha X
3 weeks Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks X
4 weeks Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know Zacks X
1 month Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha X
1 month Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks X
2 months Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors Zacks X
2 months Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo ‘Subcu’ Approval Seeking Alpha X
2 months Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha X
3 months Bristol-Myers Squibb Company (BMY) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha X
3 months Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks X
3 months Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks X
3 months Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) Seeking Alpha X
3 months Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript) Seeking Alpha X
4 months Pallas Capital Advisors LLC Purchases 9,537 Shares of Bristol-Myers Squibb (NYSE:BMY) MarketBeat X